Burden of Illness of Chronic Kidney Disease in Patients With Type 2 Diabetes - Participating Faculty

Faculty

Kevin Deon Bowrin, MSc
Team Lead
Health Economics and Outcomes Research, Cardiovascular, Renal, Vascular Diseases
Bayer PLC
Reading, United Kingdom

Eleanor O. Caplan, PhD
Research Consulting Lead
Humana Healthcare Research, Inc
Louisville, Kentucky

Meghan Cockrell, MPH
Lead Product Manager
Retail Trend and Innovation
Humana Inc
Louisville, Kentucky

Thomas Evers, PhD
Director
Integrated Evidence Generation, Therapeutic Area Cardiovascular
Bayer AG
Wuppertal, Germany

Kerstin Folkerts, MSc
Senior Project Manager
Health Economics and Outcomes Research, Cardiovascular, Renal, Vascular Diseases
Bayer AG
Wuppertal, Germany

Linda F. Fried, MD, MPH
Professor of Medicine
Epidemiology
Clinical and Translational Science
University of Pittsburgh
Pittsburgh, Pennsylvania

Csaba P. Kovesdy, MD
Fred Hatch Professor of Medicine
Division of Nephrology
University of Tennessee Health Science Center
Memphis, Tennessee

Paul Mernagh, MCom
Project Leader
Health Economics and Outcomes Research, Cardiovascular, Renal, Vascular Diseases
Bayer AG
Berlin, Germany

Aurelie Millier, PhD
HEOR Department
Creativ-Ceutical
Paris, France

Margaret K. Pasquale, PhD
Former Director
External Research Partnerships
Humana Healthcare Research, Inc
Humana Inc
Louisville, Kentucky

Niklas Schmedt, DrPH
Senior Outcomes Data Expert
Integrated Evidence Generation, Therapeutic Area Cardiovascular
Bayer AG
Berlin, Germany

Richard Sheer, BA
Research Science Lead
Humana Healthcare Research, Inc
Louisville, Kentucky

Beata Smela, MSc
HEOR Department
Creativ-Ceutical
Cracow, Poland

Michael Tindal, PharmD, MBA
Clinical Pharmacy Lead
HPS Clinical Formulary Strategies
Louisville, Kentucky

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Kevin Deon Bowrin, MSc
EMPLOYMENT
Bayer PLC
STOCK OWNERSHIP
Bayer PLC
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer AG, sponsor of the study

Eleanor O. Caplan, PhD
EMPLOYMENT
Humana Healthcare Research, Inc., a wholly owned subsidiary of Humana Inc., received funding from Bayer to conduct the study and to prepare the manuscript.

Meghan Cockrell, MPH
EMPLOYMENT
Humana Healthcare Research, Inc., a wholly owned subsidiary of Humana Inc., received funding from Bayer to conduct the study and to prepare the manuscript.
STOCK OWNERSHIP
Humana Inc

Thomas Evers, PhD
EMPLOYMENT
Bayer AG
INSTITUTIONAL CONFLICTS OF INTEREST
Compound for chronic kidney disease in patients with type 2 diabetes is in development at Bayer AG, sponsor of the study.

Kerstin Folkerts, MSc
EMPLOYMENT
Bayer AG
STOCK OWNERSHIP
Bayer AG
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer AG, sponsor of the study

Linda F. Fried, MD, MPH
CONSULTANCIES OR PAID ADVISORY BOARDS
Paid consultancy with Bayer

Csaba P. Kovesdy, MD
CONSULTANCIES OR PAID ADVISORY BOARDS
Akebia Therapeutics, Ardelyx, Astra-Zeneca, Bayer, Boehringer Ingelheim, Cara Therapeutics, Reata Pharmaceuticals, Tricida
ROYALITIES
UpToDate, Inc

Paul Mernagh, MCom
EMPLOYMENT
Bayer AG
CONSULTANCIES OR PAID ADVISORY BOARDS
Previously an independent consultant supporting Bayer in health economics outcomes research activities
INSTITUTIONAL CONFLICTS OF INTEREST
Bayer AG, sponsor of the study

Aurelie Millier, PhD
EMPLOYMENT
Creativ-Ceutical, which received funding for the conduct of this study and preparation of the manuscript

Margaret K. Pasquale, PhD
EMPLOYMENT (retired as of March 31, 2021)
Humana Healthcare Research, Inc., a wholly owned subsidiary of Humana Inc., received funding from Bayer to conduct the study and to prepare the manuscript.
STOCK OWNERSHIP
Humana Inc

Niklas Schmedt, DrPH
EMPLOYMENT
Bayer AG
INSTITUTIONAL CONFLICTS OF INTEREST
Compound for chronic kidney disease in patients with type 2 diabetes is in development at Bayer AG, sponsor of the study.

Richard Sheer, BA
EMPLOYMENT
Humana Healthcare Research, Inc., a wholly owned subsidiary of Humana Inc., received funding from Bayer to conduct the study and to prepare the manuscript.
STOCK OWNERSHIP
Humana Inc

Beata Smela, MSc
EMPLOYMENT
Creativ-Ceutical, which received funding for the conduct of this study and preparation of the manuscript

Michael Tindal, PharmD, MBA
EMPLOYMENT
Humana Pharmacy Solutions and Humana Healthcare Research, Inc., a wholly owned subsidiary of Humana Inc., received funding from Bayer to conduct the study and to prepare the manuscript.
STOCK OWNERSHIP
Humana Inc
INSTITUTIONAL CONFLICTS OF INTEREST
Humana provides health care and insurance coverage to patients with chronic kidney disease, diabetes, and renal impairments.

Download PDF